Ho Kyung Jung

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Human mesenchymal stem cells (MSCs) may be used in cell-based therapy to promote neovascularization for the treatment of ischemic diseases. However, high levels of reactive oxygen species (ROS) derived from the pathophysiological ischemic environment induce senescence and apoptosis of MSCs, resulting in reduced functionality and defective(More)
  • 1